Literature DB >> 26067960

Draft Genome Sequence of Mycobacterium obuense Strain UC1, Isolated from Patient Sputum.

Alexander L Greninger1, Gail Cunningham1, Elaine D Hsu1, Joanna M Yu1, Charles Y Chiu1, Steve Miller2.   

Abstract

We report the draft genome sequence of Mycobacterium obuense strain UC1 from a patient sputum sample. This is the first draft genome sequence of Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium.
Copyright © 2015 Greninger et al.

Entities:  

Year:  2015        PMID: 26067960      PMCID: PMC4463524          DOI: 10.1128/genomeA.00612-15

Source DB:  PubMed          Journal:  Genome Announc


GENOME ANNOUNCEMENT

Mycobacterium obuense is a rapidly growing scotochromogenic member of the genus Mycobacterium that has been previously isolated from soil and the sputum of a patient with pulmonary disease (1). The unique biochemical properties of M. obuense that resulted in it being classified as a species include its ability to degrade p-aminosalicylate and salicylate into black products. Smooth colonies of this species have been reported to be mobile, along with several other environmental mycobacteria (2). A heat-killed suspension of M. obuense has been investigated as a potential treatment for melanoma due to its stimulation of antitumor T cell response (3, 4). Rapidly growing mycobacteria constitute a commonly isolated population of acid-fast bacilli in the clinical microbiology lab of varying clinical importance (5). Their speciation via molecular methods is becoming increasingly important given the expanding numbers of immunosuppressed individuals in which they can be pathogenic. We sequenced the first draft genome of Mycobacterium obuense in order to enhance molecular methods of detection and to understand mycobacterial genetic diversity. The patient had a history of non–small cell lung cancer and presented with patchy lung infiltrates. A sputum culture for acid-fast bacilli yielded a rapidly growing scotochromogen identified by high-performance liquid chromatography as M. obuense/M. aurum. DNA from isolated colonies of strain UC1 was extracted using the Qiagen EZ1 DNA tissue kit and paired-end libraries were prepared using the Nextera XT DNA library kit followed by sequencing on the Illumina MiSeq. Sequences were adapter and quality (Q20) trimmed using cutadapt, de novo assembled using SPAdes version 3.5, metagenomically screened with SURPI, and annotated with Prokka version 1.1 (6–9). A total of 10,848,516 paired-end reads of average length 111.7 nucleotides were recovered after trimming. De novo assembly yielded 249 contigs >500 nucleotides for a total assembly size of 6,382,135 bp with an N50 of 55,467 bp, an average coverage of 148×, and a total of 6,193 coding sequences. Contiguity was most likely disrupted by high GC content (68%), and several high-copy-number integrases and transposases longer than the sequence read length. Of note, three contigs >18 kb each demonstrated 4× higher coverage than other sequences and aligned to plasmids present in M. abscessus strains with approximately 80% identity, suggesting that the UC1 strain has one or more plasmids. Pairwise alignment of available sequenced genes from Mycobacterium obuense type strain CIP 106803 (16S, hsp65, gyrB, rpoB, sod) with strain UC1 revealed 99 to 100% identity, confirming the identify as Mycobacterium obuense. The closest related complete genome to M. obuense UC1 was Mycobacterium chubuense NBB4 (81.3% identity), while the closest NCBI WGS database entry was Mycobacterium rufum JS14 (92.2% identity). Analysis by the Comprehensive Antibiotic Resistant Database identified putative resistance genes marA (55% amino acid identity to Frankia spp.), aminoglycoside resistance protein/kinase (62% amino acid identity to M. rufum JS14), two metallo-beta-lactamases (86% and 89% amino acid identity to M. rufum JS14), blaF beta-lactamase (79% amino acid to M. rufum JS14), and beta-lactamase (43% amino acid to Gordonia spp.) (10, 11).

Nucleotide sequence accession numbers.

This whole-genome shotgun project has been deposited at DDBJ/ENA/GenBank under the accession number LAUZ00000000. The version described in this paper is the second version, LAUZ02000000.
  10 in total

1.  SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing.

Authors:  Anton Bankevich; Sergey Nurk; Dmitry Antipov; Alexey A Gurevich; Mikhail Dvorkin; Alexander S Kulikov; Valery M Lesin; Sergey I Nikolenko; Son Pham; Andrey D Prjibelski; Alexey V Pyshkin; Alexander V Sirotkin; Nikolay Vyahhi; Glenn Tesler; Max A Alekseyev; Pavel A Pevzner
Journal:  J Comput Biol       Date:  2012-04-16       Impact factor: 1.479

2.  Infections due to rapidly growing mycobacteria.

Authors:  Mary A De Groote; Gwen Huitt
Journal:  Clin Infect Dis       Date:  2006-05-11       Impact factor: 9.079

3.  The comprehensive antibiotic resistance database.

Authors:  Andrew G McArthur; Nicholas Waglechner; Fazmin Nizam; Austin Yan; Marisa A Azad; Alison J Baylay; Kirandeep Bhullar; Marc J Canova; Gianfranco De Pascale; Linda Ejim; Lindsay Kalan; Andrew M King; Kalinka Koteva; Mariya Morar; Michael R Mulvey; Jonathan S O'Brien; Andrew C Pawlowski; Laura J V Piddock; Peter Spanogiannopoulos; Arlene D Sutherland; Irene Tang; Patricia L Taylor; Maulik Thaker; Wenliang Wang; Marie Yan; Tennison Yu; Gerard D Wright
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

4.  Prokka: rapid prokaryotic genome annotation.

Authors:  Torsten Seemann
Journal:  Bioinformatics       Date:  2014-03-18       Impact factor: 6.937

5.  Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis.

Authors:  P F McDermott; D G White; I Podglajen; M N Alekshun; S B Levy
Journal:  J Bacteriol       Date:  1998-06       Impact factor: 3.490

6.  Mycobacterium obuense, a rapidly growing scotochromogenic mycobacterium capable of forming a black product from p-aminosalicylate and salicylate.

Authors:  M Tsukamura; S Mizuno
Journal:  J Gen Microbiol       Date:  1971-10

7.  Surface spreading motility shown by a group of phylogenetically related, rapidly growing pigmented mycobacteria suggests that motility is a common property of mycobacterial species but is restricted to smooth colonies.

Authors:  Gemma Agustí; Oihane Astola; Elisabeth Rodríguez-Güell; Esther Julián; Marina Luquin
Journal:  J Bacteriol       Date:  2008-08-08       Impact factor: 3.490

8.  An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma.

Authors:  J Stebbing; A Dalgleish; A Gifford-Moore; A Martin; C Gleeson; G Wilson; L R Brunet; J Grange; S Mudan
Journal:  Ann Oncol       Date:  2011-09-19       Impact factor: 32.976

9.  Mycobacteria activate γδ T-cell anti-tumour responses via cytokines from type 1 myeloid dendritic cells: a mechanism of action for cancer immunotherapy.

Authors:  Daniel W Fowler; John Copier; Natalie Wilson; Angus G Dalgleish; Mark D Bodman-Smith
Journal:  Cancer Immunol Immunother       Date:  2011-10-15       Impact factor: 6.968

10.  A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples.

Authors:  Samia N Naccache; Scot Federman; Narayanan Veeraraghavan; Matei Zaharia; Deanna Lee; Erik Samayoa; Jerome Bouquet; Alexander L Greninger; Ka-Cheung Luk; Barryett Enge; Debra A Wadford; Sharon L Messenger; Gillian L Genrich; Kristen Pellegrino; Gilda Grard; Eric Leroy; Bradley S Schneider; Joseph N Fair; Miguel A Martínez; Pavel Isa; John A Crump; Joseph L DeRisi; Taylor Sittler; John Hackett; Steve Miller; Charles Y Chiu
Journal:  Genome Res       Date:  2014-06-04       Impact factor: 9.043

  10 in total
  2 in total

1.  Draft Genome Sequence of Mycobacterium parafortuitum Strain P7335.

Authors:  Jamal Saad; Anthony Levasseur; Michel Drancourt
Journal:  Microbiol Resour Announc       Date:  2018-08-30

2.  Mycobacterium obuense Bacteremia in a Patient with Pneumonia.

Authors:  Bruno Ali López Luis; Paulette Díaz-Lomelí; Livier Patricia Gómez-Albarrán; Areli Martínez-Gamboa; Alfredo Ponce-de-León
Journal:  Emerg Infect Dis       Date:  2019-05       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.